Close

Ocugen (OCGN) Enters Agreement With Washington University in St. Louis for Commercialization of Intranasal COVID-19 Vaccine in US, Europe and Japan

Go back to Ocugen (OCGN) Enters Agreement With Washington University in St. Louis for Commercialization of Intranasal COVID-19 Vaccine in US, Europe and Japan
(NASDAQ: OCGN) Delayed: 1.29 -0.04 (3.01%)
Previous Close $1.33    52 Week High
Open $1.29    52 Week Low
Day High $1.35    P/E N/A 
Day Low $1.27    EPS
Volume 4,961,731